Alkem Laboratories Ltd. | Mutual Funds
Mutual Funds that own Alkem Laboratories Ltd.
811,493
0.68%
112,436
1.41%
07/31/2018
Vanguard Emerging Markets Stock Index Fund
616,387
0.52%
-10,290
0.02%
07/31/2018
Vanguard Total International Stock Index Fund
585,613
0.49%
0
0.01%
07/31/2018
Motilal Oswal MOSt Focused Multicap 35
457,184
0.38%
-687,311
0.69%
08/31/2018
DSP BlackRock Small & Mid Cap Fund
426,518
0.36%
0
1.56%
07/31/2018
DSP BlackRock Balanced Fund
378,619
0.32%
33,757
1.41%
07/31/2018
Reliance Pharma Fund
327,523
0.27%
151,931
2.64%
08/31/2018
DSP BlackRock Opportunities Fund
314,167
0.26%
25,604
1.11%
07/31/2018
Maximiser Fund V
254,515
0.21%
254,515
0.19%
07/31/2018
Grandeur Peak International Opportunities Fund
251,198
0.21%
-44,645
0.87%
04/30/2018
| Address |
Devashish Building, Alkem House
Mumbai Maharashtra 400013
India
|
|
Employees
|
- |
| Website |
http://www.alkemlabs.com |
| Updated |
09/14/2018 |
| Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India. |
